tradingkey.logo

Entrada Therapeutics Inc - Approves Strategic Plan Focusing On DMD Programs - SEC Filing

ReutersApr 29, 2025 9:44 PM

- Entrada Therapeutics Inc TRDA.O:

  • ENTRADA THERAPEUTICS INC - APPROVES STRATEGIC PLAN FOCUSING ON DMD PROGRAMS - SEC FILING

  • ENTRADA THERAPEUTICS INC - TO REDUCE WORKFORCE BY APPROXIMATELY 20% UNDER NEW PLAN - SEC FILING

  • ENTRADA THERAPEUTICS INC - EXPECTS CASH RUNWAY TO EXTEND INTO Q2 2027 - SEC FILING

Source text: [ID:n0001104659-25-041204]

Disclaimer: The information provided on this website is for educational and informational purposes only and should not be considered financial or investment advice.

Related Articles

KeyAI